C07J 43/00

Sub-Class

Watch 2Status Updates

Stats

Description

Class  C07J : STEROIDS


Subclass 43/00: Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton

Recent Patents

Patent #TitleFiling DateIssue DatePatent Owner
12264177 Neuroactive steroids and their methods of useMar 26, 24Apr 01, 25SAGE THERAPEUTICS, INC.
12252509 Neuroactive steroids and their methods of useMar 26, 24Mar 18, 25SAGE THERAPEUTICS, INC.
12227537 Intermediates for the preparation of 11-methylene steroidsMay 13, 21Feb 18, 25CRYSTAL PHARMA, S.A.U.
12215127 Compositions and methods for profiling of gut microbiota-associated bile salt hydrolase (BSH) activityApr 15, 21Feb 04, 25Cornell Research Foundation Inc. Cornell University
12215128 (Pyridinylmethyl)butanediamine derivatives that chelate copperJul 19, 19Feb 04, 25Cold Spring Harbor Laboratory; DEPYMED, INC.;
12201640 19-nor C3,3-disubstituted C21-n-pyrazolyl steroids and methods of use thereofDec 23, 21Jan 21, 25SAGE THERAPEUTICS, INC.
12180182 (Di)amination of activated allene compounds, derivatives thereof, and methods for synthesis of the sameDec 01, 22Dec 31, 24Purdue Research Foundation
12180247 Oxysterols and methods of use thereofFeb 06, 23Dec 31, 24SAGE THERAPEUTICS, INC.
12180248 Compositions and methods for treating CNS disordersFeb 16, 23Dec 31, 24SAGE THERAPEUTICS, INC.
12139508 Steroid derivative regulators, method for preparing the same, and uses thereofJan 31, 19Nov 12, 24Jiangsu Hansoh Pharmaceutical Group Co., Ltd.; Shanghai Hansoh Biomedical Co., Ltd.;
12129275 Neuroactive steroids, compositions, and uses thereofMar 29, 22Oct 29, 24SAGE THERAPEUTICS, INC.
12122803 Crystalline forms of a neuroactive steroidMar 07, 24Oct 22, 24SAGE THERAPEUTICS, INC.
12122804 γ-aminobutyric acid modulator crystal form X, preparation method and application thereofJan 31, 19Oct 22, 24SHENZHEN RENTAI PHARMATECH LTD
12102720 Cleavable lipidsDec 20, 21Oct 01, 24Translate Bio, Inc.
12071453 Neuroactive steroids, compositions, and uses thereofSep 26, 22Aug 27, 24SAGE THERAPEUTICS, INC.
12065463 Compositions and methods for treating CNS disordersOct 24, 22Aug 20, 24SAGE THERAPEUTICS, INC.
12060386 Compositions and methods for treating CNS disordersApr 24, 23Aug 13, 24SAGE THERAPEUTICS, INC.
11998901 Metal complex, method for producing same, and method for producing gamma-lactam compound using sameFeb 18, 22Jun 04, 24Institute for Basic Science; Korea Advanced Institute of Science and Technology;
11999765 Neuroactive steroids and their methods of useJun 13, 23Jun 04, 24SAGE THERAPEUTICS, INC.
11993628 C7, C12, and C16 substituted neuroactive steroids and their methods of useApr 28, 21May 28, 24SAGE THERAPEUTICS, INC.

more results

Recent Publications

Publication #TitleFiling DatePub DatePatent Owner
2025/0092,084 C7, C12, AND C16 SUBSTITUTED NEUROACTIVE STEROIDS AND THEIR METHODS OF USEApr 16, 24Mar 20, 25Not available
2025/0073,249 STEROID COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOFJan 06, 23Mar 06, 25Not available
2025/0049,727 COMPOSITIONS FOR THE DELIVERY OF PAYLOAD MOLECULES TO AIRWAY EPITHELIUMNov 10, 22Feb 13, 25Not available
2025/0051,387 STEROID DERIVATIVE REGULATORS, METHOD FOR PREPARING THE SAME, AND USES THEREOFOct 01, 24Feb 13, 25Not available
2025/0042,934 COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERSFeb 20, 24Feb 06, 25Not available
2025/0034,201 PRODRUGS OF GANAXOLONESep 05, 24Jan 30, 25Not available
2025/0034,200 Prodrugs of Neurosteroid Analogs and Uses ThereofNov 10, 22Jan 30, 25Not available
2025/0026,781 Prodrugs of Neurosteroid Analogs and Uses ThereofNov 10, 22Jan 23, 25Not available
2025/0002,525 Aminosteroids for the Treatment of a PTP1B Associated DiseaseJan 29, 24Jan 02, 25DEPYMED, INC.
2024/0408,020 Lyophilized Pharmaceutical Compositions Comprising a Lipid NanoparticleAug 27, 24Dec 12, 24Translate Bio, Inc.
2024/0408,124 GPX4 Inhibitors and Senolytic Compounds and Uses ThereofMay 30, 24Dec 12, 24Not available
2024/0391,948 NOVEL COMPOUND THAT INHIBITS TNF-ALPHA GENERATION AND INFLAMMASOME ACTIVITY AND PREPARATION METHOD THEREFORJul 26, 22Nov 28, 24Not available
2024/0376,144 NEUROACTIVE STEROIDS SUBSTITUTED IN POSITION 10 WITH A CYCLIC GROUP FOR USE IN THE TREATMENT OF CNS DISORDERSFeb 21, 23Nov 14, 24Not available
2024/0376,145 STEROIDAL COMPOUND DERIVATIVES AS THERAPEUTIC AGENTSDec 17, 21Nov 14, 24University of Florida Research Foundation, Incorporated
2024/0368,213 COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERSJun 12, 24Nov 07, 24Not available
2024/0342,307 Liver Specific Delivery of Messenger RNAFeb 02, 24Oct 17, 24Translate Bio, Inc.
2024/0343,756 NEUROACTIVE STEROIDS AND THEIR METHODS OF USEMar 26, 24Oct 17, 24Not available
2024/0343,755 STABLE ISOQUINOLINE-CORTICOSTEROID CONJUGATES AND USES THEREOFApr 29, 22Oct 17, 24Not available
2024/0327,452 Bile Acid Derivatives as FXR/TGR5 Agonists and Methods of Use ThereofMar 05, 24Oct 03, 24Not available
2024/0317,729 Compounds & Methods for the Enhanced Degradation of Targeted Proteins & Other Polypeptides by an E3 Ubiquitin LigaseMay 17, 24Sep 26, 24Not available

more results

Top Owners in This Subclass

Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More

Patents Issued To Date - By Filing Year

Average Time to Issuance